The American College of Obstetricians and Gynecologists is recommending that women take a pill called cialistin, the first approved contraceptive in the U.S. since the pill was first developed in the 1980s.
In the past few years, the association has also said that women should start taking a pill to prevent ovarian cancer in women.
Cialistine is a prescription drug, and some insurance plans have already started covering it for people with pre-existing conditions.
But some women, including some doctors and insurers, say the pill isn’t worth the risks.
The drug’s makers say it’s effective and will reduce your risk of a heart attack or stroke.
But a new study published in the journal JAMA Internal Medicine suggests that, if taken at all, the pill is no more effective than other contraceptives.
The new study found that in women taking cialists in the previous two years, a pill that contained cialismine increased the risk of heart attacks, strokes, cancer and diabetes by 28 percent.
The authors said the pill’s safety is an issue for women considering a medical or financial decision about whether or not to have a baby.
The study was led by Dr. Joseph Buehler, a professor of medicine at the Johns Hopkins Bloomberg School of Public Health and director of the Johns Paulson Institute for Biomedical Research in New York.
He is the lead author of the JAMA study.
It looked at about 4,000 women who were treated for CID-19 in the last year.
The women had to have had heart disease, high blood pressure or diabetes before they were treated, and were between the ages of 18 and 45.
After two years of treatment, the researchers found that those who took the pill had a 1.6-fold increased risk of dying than those who didn’t.
Women who took it between January and April of last year had a 2.3-fold increase.
“There’s this huge public health concern about the pill, so we were concerned that it was a risk factor for death,” Buehl said.
The researchers did not see a difference in the incidence of any other diseases, including cancer, strokes and heart disease.
A few other studies have also found that women who take cialistic drugs are less likely to get cervical cancer, but the association is relatively small and not statistically significant.
Some people are worried about taking the pill because they think it will lead to infertility, but there are other studies that suggest it does not lead to a higher risk of pregnancy loss, according to the researchers.
Ciboxen, which contains cialictein, has been used for years by gynecologists to prevent ovulation.
The pill has been shown to reduce ovulation in women, but that hasn’t been proven to be a big benefit for women.
Women have long known that women with a uterus can benefit from cialiscin, but few studies have looked at the impact of the pill on the uterus.
The JAMA authors looked at women who had been treated with cialisms for CIDs-19 for at least a year, and women who also had ovarian cancer, and compared their outcomes with women who didn.
Women taking ciboxetine and those who had ovulatory cycles during the study had lower rates of heart attack and strokes.
“We’re concerned about what we don’t know, but this study shows that cialite may be a very effective and safe way to prevent the risk for ovulation, but we don-t know what effect it would have on ovarian cancer,” Buedhler said.
Cid-19 is a rare genetic disorder that causes inflammation of the uterus that leads to irregular bleeding.
It usually affects women who have a genetic mutation that makes it harder to make ovulation hormones.
The U.K.-based NHS Trusts Women’s NHS (NTWN) and other groups have begun recommending ciali in the first trimester of pregnancy for women with CIDs, and it is currently available for men and women.
The National Institutes of Health has said that the drug will not be recommended for women in the early stages of pregnancy.